FDA Advisory Panel Gives Thumbs-Up to AstraZeneca’s Brilinta


Published On: July 29th, 2010

Overall, patients taking Brilinta showed a 16% benefit compared to those taking Plavix, the market leader.

View original post here: 
FDA Advisory Panel Gives Thumbs-Up to AstraZeneca’s Brilinta



Loading...


Comments are closed.